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Reply
Fractional Flow Reserve: A Good or a Gold
Standard?“Coronary pressure NEVER lies.”
dKoolen and Pijls (1)
0.81, or indeed defer some wit
automatically irresponsible or car“.the authors took the responsibility and conse-
quences of their actions by STRICTLY adhering to
treating patients with FFR <0.80 and deferring
patients with FFR >0.80.”
dPijls and Tonino (2)
Sayan Sen, MB BS
Mauro Echavarria-Pinto, MDWe thank Dr. Johnson and colleagues and Dr. Fan and col-
leagues for their interest in our work (3).
Fractional ﬂow reserve (FFR) has come a long way over the last
20 years, from an upstart to what is now commonly proposed as
an infallible gold standard for the detection of myocardial ischemia.
The brilliance of the pioneer clinical scientists who forged their way
forward against skepticism may understandably have moved them
to exceptional heights of eloquence and may explain why the
inherent limitations of this valuable technique have never been
openly discussed. Our reﬂections on FFR variability (3) do not
question the value of FFR, a tool that we use every day in our
laboratory as a guide to treatment decisions. We simply addressed
the potential limitations of a dichotomous interpretation of FFR
results. Our aim was to help clinicians see that FFR, like all other
measurements in medicine, does not carry strict dichotomous im-
plications for which treatment is best, and this is especially true
close to the cutoff.
Dr. Johnson and colleagues point out that we used only the
data salvaged from oblivion through publication by Kern et al.
(4), because the original DEFER study data seem to have been
mislaid, unfortunatelydan increasingly common problem with
pivotal FFR datasets. They are also right that our methodology
perhaps inﬂuenced our results. However, may we correct them:we underestimated FFR variability (SD of difference) at only
3.2%. The DEFER study reported only mean absolute difference,
from which SD of difference can be derived as 3.7%. We have
explored this issue in more details in a recent publication (5),
from which readers can test the FFR intrinsic variability in their
own samples.
Dr. Johnson and colleagues and Dr. Fan and colleagues also
cast doubts on our analysis because of the old pressure guidewire
technology used in the DEFER study. Do they suggest that the
positive results of the DEFER study should be re-examined?
Also, should these concerns be extended to the validity of other
early pivotal FFR studies? We should recall that the most
important piece of evidence on the diagnostic efﬁciency of FFR in
identifying ischemia-generating stenoses comes from a study of 46
patients, investigated nearly 20 years ago with even older pressure
wires (6). Reassuringly, using state-of-the art wire technology,
Ntalianis et al. (7) recently reported the test–retest variability of
FFR to be 5% when taken more than 24 h apart, demonstrating
elegantly that FFR measurement variability is a true biological
phenomenon.
We do agree with Dr. Fan and colleagues that clinicians should
assess test–retest reproducibility of FFR in their own hands and
make repeated measurements of FFR when facing intermediate
values. We merely recommend parsimony, both with adenosine
and with references to golden infallibility. Clinicians must inte-
grate many aspects of lesion and patient characteristics into their
decisions. If clinicians sometimes stent stenoses with an FFR ¼
h an FFR ¼ 0.74, they are not
eless.
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1274–81.Precise Location of Ideal Common
Femoral Artery Puncture Site
The article by Toggweiler et al. (1) on vascular access with large-
sheath cannulation of the common femoral artery was an excellent
review for physicians performing transvascular aortic valve or
endovascular aneurysm repair procedures. However, I believe their
description of the ideal femoral puncture site was not good. From a
clinical, interventional perspective, the ideal common femoral
puncture site is between the femoral bifurcation and the inferior
border of the inferior epigastric artery (2). The inferior border and
the origin of the inferior epigastric artery are commonly not theFigure 1. Basic Iliofemoral Anatomy
The external iliac artery passes under the inguinal ligament, at which point it is r
external iliac artery, just above the inguinal ligament and serves as a useful landma
Q5 of the common iliac artery, the external iliac artery, and the common femorasame. This is shown in Figure 1 of the paper by Toggweiler et al.
(1). Punctures above the inferior sweep or lowest border of the
inferior epigastric artery are commonly associated with retroperi-
toneal hemorrhage.
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Reply: Precise Location of Ideal Common Femoral
Artery Puncture Site
We thank Dr. Feldman for his interest in our paper (1). We
agree with Dr. Feldman. Retroperitoneal bleeding may occurenamed the common femoral artery. The inferior epigastric artery arises from the
rk to demarcate the retroperitoneal space (A). The average minimal artery diameter
l artery are shown (B).
